Graticule Asia Macro Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Graticule Asia Macro Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,000	Closed	-$1.11M	–	209
2021 Q1	$1.11M	Sell	25,000 -10,790	-30%	-$592K	0.18%	112
2020 Q4	$1.96M	Buy	+35,790	New	+$1.3M	0.94%	38
2017 Q3	–	Sell	-4,054	Closed	-$31K	–	118
2017 Q2	$31K	Hold	4,054	–	–	﹤0.01%	110
2017 Q1	$32K	Hold	4,054	–	–	﹤0.01%	120
2016 Q4	$99K	Sell	4,054 -12,575	-76%	-$359K	0.01%	98
2016 Q3	$631K	Hold	16,629	–	–	0.04%	91
2016 Q2	$495K	Hold	16,629	–	–	0.05%	45
2016 Q1	$492K	Sell	16,629 -20,371	-55%	-$611K	0.04%	75
2015 Q4	$1.68M	Hold	37,000	–	–	0.27%	58
2015 Q3	$1.39M	Buy	+37,000	New	+$1.7M	0.16%	63

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Graticule Asia Macro Advisors's RCKT Position: Q2 2021 in Review

Graticule Asia Macro Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q2 2021, closing a stake of 25,000 shares — an estimated $1.11M sold.

Graticule Asia Macro Advisors first reported a position in RCKT in Q3 2015 and held it in 10 quarters. The position peaked at $1.96M in Q4 2020. 150 funds tracked by Wall St. Rank hold RCKT as of Q2 2021.

Graticule Asia Macro Advisors reported no remaining Rocket Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Graticule Asia Macro Advisors sold 25,000 Rocket Pharmaceuticals shares in Q2 2021, an estimated $1.11M.
Graticule Asia Macro Advisors first reported a position in Rocket Pharmaceuticals in Q3 2015 and held it in 10 quarters.
Graticule Asia Macro Advisors's Rocket Pharmaceuticals position peaked at $1.96M in Q4 2020.
150 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2021.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.